Referenser och regelverk

    Innehållet är grundat på beprövad erfarenhet, lagar, regelverk, nationella riktlinjer och med stöd från relevanta vetenskapliga studier.  

    Referenser

    1. Frykholm P, Pikwer A, Hammarskjold F, Larsson AT, Lindgren S, Lindwall R, et al. Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2014;58(5):508-24.
    2. Acosta S, Frykholm P, Granath A, Hammarskjöld F, Lindgren S, Lindwall R et al. Riktlinjer för central venkateterisering. Svensk förening för anestesi och intensivvård (SFAI); 2018.
    3. Folkhälsomyndigheten. Att förebygga vårdrelaterade infektioner: ett kunskapsunderlag. Stockholm: Socialstyrelsen; 2006. [citerad 2023-08-16];
    4. Esposito MR, Guillari A, Angelillo IF. Knowledge, attitudes, and practice on the prevention of central line-associated bloodstream infections among nurses in oncological care: A cross-sectional study in an area of southern Italy. PLoS One. 2017;12(6):e0180473:
    5. Velasquez Reyes DC, Bloomer M, Morphet J. Prevention of central venous line associated bloodstream infections in adult intensive care units: A systematic review. Intensive Crit Care Nurs. 2017;
    6. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control. 2008;36(10):S171 e 1-5.
    7. Gorski LA. Implementing Home Health Standards in Clinical Practice. Home Healthc Now. 2016;34(2):76-85.
    8. Gorski L, Hadaway L, Hagle M, McGoldrick M, Orr M, Doellman D.. Infusion therapy standards of practice. J Infus Nurs. 2016;39 (Suppl. 1):1-159.
    9. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin; 2008.
    10. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e:162-63.
    11. El Ters M, Schears GJ, Taler SJ, Williams AW, Albright RC, Jenson BM, et.al. Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients. Am J Kidney Dis. 2012;60(4):601-8.
    12. Dale M, Higgins A, Carolan-Rees G. Sherlock.. Tip Confirmation System for Placement of Peripherally Inserted Central Catheters 3CG((R)). A NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2016;14(1):41-9.
    13. Walker G, Chan RJ, Alexandrou E, Webster J, Rickard C. Effectiveness of electrocardiographic guidance in CVAD tip placement. Br J Nurs. 2015;24(14):s14, s6,s8-12.
    14. Storey S, Brown J, Foley A, Newkirk E, Powers J, Barger J, et al. A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trial. Am J Infect Control. 2016;44(6):636-41.
    15. Slater K, Cooke M, Fullerton F, Whitby M, Hay J, Lingard S, Douglas J, Rickard CM. Peripheral intravenous catheter needleless connector decontamination study-Randomized controlled trial. Am J Infect Control. 2020;48(9):1013-1018.
    16. Macklin D. Catheter management. Semin Oncol Nurs. 2010;26(2):113-20.
    17. Moureau NL, Flynn J. Disinfection of Needleless Connector Hubs: Clinical Evidence Systematic Review. Nurs Res Pract. 2015;
    18. Pittet D, Allegranzi B, Boyce: World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts. The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect Control Hosp Epidemiol. 2009;30(7):611-22.
    19. Conley SB. Central Line-Associated Bloodstream Infection Prevention: Standardizing Practice Focused on Evidence-Based Guidelines. Clin J Oncol Nurs. 2016;20(1):23-6.
    20. Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev; 2011.
    21. Kelly LJ, Jones T, Kirkham S. Needle-free devices: keeping the system closed. Br J Nurs. 2017;26(2):14-9.
    22. Douglas L, Aspin A, Jimmeson N, Lawrance V. Central venous access devices: review of practice. Paediatr Nurs. 2009;21(5):19-22.
    23. Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009;28(4):365-77.
    24. Goldberg JL. Guideline Implementation: Hand Hygiene. Aorn j. 2017;105(2):203-12.
    25. Kaler W, Chinn R. Successful Disinfection of Needleless Access Ports: A Matter of Time and Friction. The Journal of the Association for Vascular Access. 2007;12(3):140-2.
    26. Elen Hughes M. Reducing PICC migrations and improving patient outcomes.. Br J Nurs. 2014;23(2):12, 14-8.
    27. Egan GM, Siskin GP, Weinmann Rt, Galloway MM. A prospective postmarket study to evaluate the safety and efficacy of a new peripherally inserted central catheter stabilization system. J Infus Nurs. 2013;36(3):181-8.
    28. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. Heparin flushing and other interventions to maintain patency of central venous catheters: A systematic review. J Adv Nurs. 2009;65:2007-21.
    29. Adolfsson A, Klefsgård R, Troeng M. Spolning av CVK och subkutan venport med heparin eller enbart NaCl. Malmö: Skånes universitetssjukhus, enheten för HTA; 2013.
    30. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med. 2005;142(6):451-66.
    31. Li J, Fan YY, Xin MZ, Yan J, Hu W, Huang WH, Lin XL, Qin HY. A randomised controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using B-mode ultrasound with modified Seldinger technique versus blind puncture. European J of Oncology Nursing. 2014;18:94-103.
    32. Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study).. J Thromb Haemost. 2007;5(8):1650-3.
    33. Zwicker JI, Connolly G, Carrier M, Kamphuisen PW, Lee AY. Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2014;12(5):796-800.
    34. Ellis ML et al. Catheter-related thrombosis incidence and risk factors in adult cancer patients with central venous access devices. Intern Med J. 2020;feb11:doi: 10.1111/imj.14780.
    35. Chopra V et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382(9889):3011-25.
    36. Clatot F et al. Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer. Eur J Cancer. 2020;126:116-124.
    37. Mansour et al. The Application of Current Proposed Venous Thromboembolism Risk Assessment Model for Ambulatory Patients With Cancer. Clin Appl Thromb Hemost. 2018;24(3):429-433.
    38. Patel GS et al. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Supp Care Cancer. 2014;22(1):121-8.
    39. Pikwer A, Åkeson J, Lindgren S. Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia. 2012;67(1):65-71.
    40. Pu Y et al. Complications and Costs of Peripherally Inserted Central Venous Catheters Compared With Implantable Port Catheters for Cancer Patients: A Meta-analysis. Cancer Nurs. 2019;Aug 27:doi: 10.1097.
    41. Taxbro K, Hammarskjöld F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Br J Anaesth. 2019;122(6):734-741.
    42. Mermel LA, Farr BM, Sherertz RJ, Raad, II, O'Grady N, Harris JS, et al.. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32(9):1249-72.
    43. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
    44. Pérez Fidalgo JA, García Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F: ESMO. Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines. Ann Oncol. 2012;23 Suppl 7:167-73..
    45. Macklin D. Removing a PICC. Am J Nurse. 2000;100(1):52-4.

    Regelverk

    Revideringsdatum:
    2022-08-22
    Författare:
    Anette Grahn, leg. sjuksköterska, verksamhetschef Cancer och lungsjukvårdsenheten, Centrum för kirurgi, ortopedi och cancervård, Region Östergötland Christina Ågebrant, leg. sjuksköterska, Behandlingsmottagningen, Onkologiska kliniken, Universitetssjukhuset, Linköping
    Faktagranskare:
    Knut Taxbro, överläkare, med.dr, Operations- och intensivvårdskliniken, Länssjukhuset Ryhov, Jönköping
    Till toppen av sidan